Company intelligence / Profile preview

Accelerated Biosciences

Philadelphia, Pennsylvania, USAacceleratedbio.com ↗
Ownership
Private
Development stage
Preclinical
01

Overview

Accelerated Biosciences is leveraging hTSCs for regenerative medicine, focusing on their immune privilege, genetic stability, and high expansion capacity. They have partnerships to accelerate therapeutic product development.

Therapeutic areas
OtherImmunology
Modalities
Cell TherapyGene Therapy
Industry
Biotech
02

Drug pipeline

1 asset

human trophoblast stem cell-derived natural killer cells

Unknown
03

Partnerships

Agathos BiologicsStemmatters

Beyond the preview

Go deeper on Accelerated Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Accelerated Biosciences.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call